Overview
- 5 inspections across 5 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-07-21.
At a glance
Inspections
5
Sites
5
Observations
0
Career since
Sep 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Janssen Sciences Ireland UC | 21 Jul 2017 | Human Drugs | |
| Avid Bioservices Inc. | 9 Feb 2017 | Human Drugs | |
| Biomarin Pharmaceutical Inc. | 25 Aug 2016 | Human Drugs | On file |
| Regeneron Pharmaceuticals, Inc. | 5 Feb 2016 | Human Drugs | |
| Lonza Biologics, Inc. | 19 Sep 2014 | Human Drugs |
Sites inspected
Janssen Sciences Ireland UCRingaskiddy, Ireland1 insp.
Avid Bioservices Inc.Tustin, United States1 insp.
Biomarin Pharmaceutical Inc.Novato, United States1 insp.
Regeneron Pharmaceuticals, Inc.Rensselaer, United States1 insp.
Lonza Biologics, Inc.Portsmouth, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Thuy T Nguyen1 shared
Laura Fontan1 shared
Full investigator report
Get the verbatim findings behind Candace Y Gomez-Broughton's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site